A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...

While it's not an overnight miracle, PhenQ provides a powerful edge for men committed to transforming their physique and ...

Scientists have developed a new once-a-day oral treatment for obesity that mimics metabolic effects of gastric bypass without ...

For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Whether it's drawing blood or administering medication, needles scare many people, and not everyone can imagine doing it ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and effective redirection of nutrient absorption into ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and ...

Elon Musk's AI bot Grok's answer to who Donald Trump's overweight friend whom he says 'took the fat shot drug' is likely ...

One of the standout features of purchasing HepatoBurn is the 60-day, no-questions-asked money-back guarantee. If you're not ...

Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ETCompany ParticipantsTara Brady - Interim CFOShantanu Gaur ...

REVEAL-1 Cohort 3-month open-label data update expected in June 2025; early clinical signals reinforce Revita's potential to maintain weight loss aft ...